MA54283A - Pyrazoles utilisés utilisés comme modulateurs de l'hémoglobine - Google Patents
Pyrazoles utilisés utilisés comme modulateurs de l'hémoglobineInfo
- Publication number
- MA54283A MA54283A MA054283A MA54283A MA54283A MA 54283 A MA54283 A MA 54283A MA 054283 A MA054283 A MA 054283A MA 54283 A MA54283 A MA 54283A MA 54283 A MA54283 A MA 54283A
- Authority
- MA
- Morocco
- Prior art keywords
- pyrazoles
- hemoglobin modulators
- hemoglobin
- modulators
- pyrazoles used
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862772815P | 2018-11-29 | 2018-11-29 | |
US201962915784P | 2019-10-16 | 2019-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA54283A true MA54283A (fr) | 2022-03-09 |
Family
ID=68807213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA054283A MA54283A (fr) | 2018-11-29 | 2019-11-26 | Pyrazoles utilisés utilisés comme modulateurs de l'hémoglobine |
Country Status (22)
Country | Link |
---|---|
US (3) | US11014908B2 (fr) |
EP (1) | EP3886984A1 (fr) |
JP (1) | JP2022510628A (fr) |
KR (1) | KR20210097161A (fr) |
CN (1) | CN113329789A (fr) |
AU (1) | AU2019387290A1 (fr) |
BR (1) | BR112021009057A2 (fr) |
CA (1) | CA3121139A1 (fr) |
CO (1) | CO2021006924A2 (fr) |
CR (1) | CR20210284A (fr) |
CU (1) | CU20210044A7 (fr) |
DO (1) | DOP2021000103A (fr) |
EC (1) | ECSP21037191A (fr) |
IL (1) | IL283408A (fr) |
MA (1) | MA54283A (fr) |
MX (1) | MX2021006095A (fr) |
PE (1) | PE20211592A1 (fr) |
PH (1) | PH12021551035A1 (fr) |
SG (1) | SG11202104585YA (fr) |
TW (2) | TW202140452A (fr) |
UY (1) | UY38488A (fr) |
WO (1) | WO2020109994A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CR20210284A (es) * | 2018-11-29 | 2021-07-09 | Pfizer | Pirazoles como modulares de hemoglobina |
JP7449390B2 (ja) | 2020-01-24 | 2024-03-13 | ファイザー・インク | 抗e-セレクチン抗体、組成物および使用の方法 |
CN112079774A (zh) * | 2020-10-17 | 2020-12-15 | 甘肃天后光学科技有限公司 | 软性隐形眼镜用蓝光吸收剂、其制备方法及应用方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
US7169797B2 (en) | 2003-02-14 | 2007-01-30 | Abbott Laboratories | Protein-tyrosine phosphatase inhibitors and uses thereof |
US20040167188A1 (en) | 2003-02-14 | 2004-08-26 | Zhili Xin | Protein-tyrosine phosphatase inhibitors and uses thereof |
EP1760071A4 (fr) | 2004-06-23 | 2008-03-05 | Ono Pharmaceutical Co | Composé ayant une activité de liaison aux récepteurs s1p et utilisation de celui-ci |
WO2006003923A1 (fr) | 2004-06-30 | 2006-01-12 | Sankyo Company, Limited | Composé du benzène substitué |
JP2007176799A (ja) | 2005-12-27 | 2007-07-12 | Sankyo Co Ltd | 置換ベンゼン化合物を含有する医薬 |
US8039442B2 (en) | 2007-07-18 | 2011-10-18 | Glycomimetics, Inc. | Compounds and methods for treatment of sickle cell disease or complications associated therewith |
WO2011015524A2 (fr) | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Dérivés dhétérocycles fongicides |
CN102206172B (zh) | 2010-03-30 | 2015-02-25 | 中国医学科学院医药生物技术研究所 | 一组取代双芳基化合物及其制备方法和抗病毒应用 |
WO2011138751A2 (fr) * | 2010-05-04 | 2011-11-10 | Pfizer Inc. | Dérivés hétérocycliques destinés au traitement de maladies |
EP2616442B8 (fr) | 2010-09-14 | 2018-10-17 | Exelixis, Inc. | Inhibiteurs de pi3k-delta et leurs procédés d'utilisation et fabrication |
WO2012129562A2 (fr) | 2011-03-24 | 2012-09-27 | The Scripps Research Institute | Composés et procédés pour l'induction de la chondrogenèse |
WO2013102145A1 (fr) | 2011-12-28 | 2013-07-04 | Global Blood Therapeutics, Inc. | Composés d'aldéhydes hétéroaryles substitués et leurs procédés d'utilisation dans l'accroissement de l'oxygénation tissulaire |
CN104135859B (zh) | 2011-12-28 | 2017-06-27 | 全球血液疗法公司 | 取代的苯甲醛化合物及其用于增加组织氧合的方法 |
WO2014150289A1 (fr) | 2013-03-15 | 2014-09-25 | Global Blood Therapeutics, Inc. | Composés et leurs utilisations pour la modulation de l'hémoglobine |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
SG11201507453VA (en) | 2013-03-15 | 2015-10-29 | Global Blood Therapeutics Inc | Compounds and uses thereof for the modulation of hemoglobin |
JP6463327B2 (ja) | 2013-03-15 | 2019-01-30 | グローバル ブラッド セラピューティクス インコーポレイテッド | ヘモグロビンの修飾のための化合物及びその使用 |
JP6426694B2 (ja) | 2013-03-15 | 2018-11-21 | グローバル ブラッド セラピューティクス インコーポレイテッド | ヘモグロビンの修飾のための化合物及びその使用 |
US20140271591A1 (en) * | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compositions and methods for the modulation of hemoglobin (s) |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9248199B2 (en) * | 2014-01-29 | 2016-02-02 | Global Blood Therapeutics, Inc. | 1:1 adducts of sickle hemoglobin |
JP2017518339A (ja) | 2014-06-20 | 2017-07-06 | インスティチュート パスツール コリア | 抗感染化合物 |
WO2016043849A2 (fr) | 2014-07-24 | 2016-03-24 | Global Blood Therapeutics, Inc. | Composés pour traiter le syndrome de détresse respiratoire aigu ou son effet négatif |
EP3215514B1 (fr) | 2014-11-03 | 2018-11-21 | F. Hoffmann-La Roche AG | Inhibiteurs de bace1 |
JP6914834B2 (ja) | 2014-11-16 | 2021-08-04 | アレイ バイオファーマ インコーポレイテッド | (S)−N−(5−((R)−2−(2,5−ジフルオロフェニル)−ピロリジン−1−イル)−ピラゾロ[1,5−a]ピリミジン−3−イル)−3−ヒドロキシピロリジン−1−カルボキサミド硫酸水素塩の結晶形 |
EP3383392A1 (fr) | 2015-12-04 | 2018-10-10 | Global Blood Therapeutics, Inc. | Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde |
EP3472150A1 (fr) | 2016-06-17 | 2019-04-24 | Fronthera U.S. Pharmaceuticals LLC | Composés modificateurs d'hémoglobine et leurs utilisations |
CN109843294A (zh) | 2016-08-15 | 2019-06-04 | 普渡研究基金会 | 4-取代的氨基异喹啉衍生物 |
CR20210284A (es) * | 2018-11-29 | 2021-07-09 | Pfizer | Pirazoles como modulares de hemoglobina |
-
2019
- 2019-11-26 CR CR20210284A patent/CR20210284A/es unknown
- 2019-11-26 MA MA054283A patent/MA54283A/fr unknown
- 2019-11-26 CA CA3121139A patent/CA3121139A1/fr not_active Abandoned
- 2019-11-26 WO PCT/IB2019/060171 patent/WO2020109994A1/fr active Application Filing
- 2019-11-26 MX MX2021006095A patent/MX2021006095A/es unknown
- 2019-11-26 TW TW110125518A patent/TW202140452A/zh unknown
- 2019-11-26 AU AU2019387290A patent/AU2019387290A1/en not_active Abandoned
- 2019-11-26 PE PE2021000762A patent/PE20211592A1/es unknown
- 2019-11-26 EP EP19816457.6A patent/EP3886984A1/fr not_active Withdrawn
- 2019-11-26 JP JP2021529740A patent/JP2022510628A/ja active Pending
- 2019-11-26 US US16/695,709 patent/US11014908B2/en active Active
- 2019-11-26 CU CU2021000044A patent/CU20210044A7/es unknown
- 2019-11-26 BR BR112021009057-6A patent/BR112021009057A2/pt not_active Application Discontinuation
- 2019-11-26 KR KR1020217020051A patent/KR20210097161A/ko not_active Application Discontinuation
- 2019-11-26 SG SG11202104585YA patent/SG11202104585YA/en unknown
- 2019-11-26 CN CN201980090794.6A patent/CN113329789A/zh active Pending
- 2019-11-26 TW TW108142940A patent/TWI736037B/zh not_active IP Right Cessation
- 2019-11-27 UY UY0001038488A patent/UY38488A/es not_active Application Discontinuation
-
2021
- 2021-04-12 US US17/227,819 patent/US11702405B2/en active Active
- 2021-05-05 PH PH12021551035A patent/PH12021551035A1/en unknown
- 2021-05-24 IL IL283408A patent/IL283408A/en unknown
- 2021-05-25 EC ECSENADI202137191A patent/ECSP21037191A/es unknown
- 2021-05-26 DO DO2021000103A patent/DOP2021000103A/es unknown
- 2021-05-26 CO CONC2021/0006924A patent/CO2021006924A2/es unknown
-
2023
- 2023-05-24 US US18/322,844 patent/US20230382892A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20210097161A (ko) | 2021-08-06 |
US11014908B2 (en) | 2021-05-25 |
UY38488A (es) | 2020-06-30 |
BR112021009057A2 (pt) | 2021-08-10 |
US20230382892A1 (en) | 2023-11-30 |
CA3121139A1 (fr) | 2020-06-04 |
US11702405B2 (en) | 2023-07-18 |
TWI736037B (zh) | 2021-08-11 |
TW202033513A (zh) | 2020-09-16 |
CO2021006924A2 (es) | 2021-06-10 |
JP2022510628A (ja) | 2022-01-27 |
CR20210284A (es) | 2021-07-09 |
CN113329789A (zh) | 2021-08-31 |
SG11202104585YA (en) | 2021-06-29 |
DOP2021000103A (es) | 2021-07-30 |
ECSP21037191A (es) | 2021-06-30 |
AU2019387290A1 (en) | 2021-05-27 |
CU20210044A7 (es) | 2022-01-13 |
TW202140452A (zh) | 2021-11-01 |
US20200172512A1 (en) | 2020-06-04 |
IL283408A (en) | 2021-07-29 |
PH12021551035A1 (en) | 2021-12-06 |
PE20211592A1 (es) | 2021-08-18 |
US20220348555A1 (en) | 2022-11-03 |
EP3886984A1 (fr) | 2021-10-06 |
MX2021006095A (es) | 2021-07-06 |
WO2020109994A1 (fr) | 2020-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52486A (fr) | Pyridazinones utilisés en tant qu'inhibiteurs de parp7 | |
MA44008A (fr) | 1,2,3-triazoles substitués utilisés comme modulateurs de nmda sélectifs de nr2b | |
EP3740478C0 (fr) | Dérivés d'imidazole fusionnés utilisés en tant qu'inhibiteurs d'il-17 | |
GB201908442D0 (en) | Lens Platform 2 | |
IL283128A (en) | 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin | |
MA47013A (fr) | Composés benzolactames utilisés en tant qu'inhibiteurs de protéine kinase | |
MA54283A (fr) | Pyrazoles utilisés utilisés comme modulateurs de l'hémoglobine | |
DK3767753T3 (da) | Konnektor | |
MA53924A (fr) | Modulateurs de l'expression d'apol1 | |
DK3720433T3 (da) | Bis-cholin-tetrathiomolybdat til behandling af wilsons sygdom | |
MA46261A (fr) | Instruments applicateurs ayant des manches articules pour distribuer des agrafes chirurgicales | |
MA51864A (fr) | Méthodes d'identification de composés | |
MA53479A (fr) | Composés hétérocycliques en tant q'inibiteurs de vanin | |
MA56030A (fr) | Pyrrolidinones substituées par un pyrazole utilisés comme herbicides | |
MA51795A (fr) | Oligonucléotides pour moduler l'expression de tmem106b | |
MA51645A (fr) | Modulateurs de l'expression de dnm2 | |
HK1257772A1 (zh) | 增强通信網絡對終端設備位置的了解的準確性 | |
IL279820A (en) | Communication bridge | |
SG11202010971XA (en) | Small molecule modulators of mhc-i | |
IT201900022977A1 (it) | Cavo elettro-ottico | |
FR3062793B1 (fr) | Utilisation de 2,5-dicetopiperazines en tant qu'agents cosmetiques | |
UA36982S (uk) | Крос польовий для телекомунікаційного зв'язку | |
GB201908319D0 (en) | Pionka's truffin | |
UA40066S (uk) | Горщик дитячий | |
UA38939S (uk) | Велобіг-мотоцикл дитячий |